DaTSCAN™

Amersham International acquires Cygne BV in The Netherlands, where DaTSCAN™ molecular diagnostic for objective identification of Parkinson's was developed. The product was launched in 2000.

< Previous Next >
Key:
  The Radiochemical Centre; Amersham International; Nycomed Amersham; Amersham plc
  Nycomed; Nycomed Amersham Imaging; Amersham Health
  Pharmacia; Pharmacia Biotech; Amersham Pharmacia Biotech; Amersham Biosciences

About us - Investors - Our businesses - News & events - Home

© Amersham plc 2003 - All rights reserved. Legal information